期刊文献+

复方异丙托溴铵联合布地奈德对支气管哮喘患儿血管内皮生长因子与转化生长因子β_(1)和单核细胞趋化蛋白4水平及肺功能的影响 被引量:18

Effects of compound ipratropium bromide combined with budesonide on vascular endothelial growth factor,transforming growth factor-β_(1),monocyte chemoattractant protein-4 levels and pulmonary function in children with bronchial asthma
下载PDF
导出
摘要 目的分析复方异丙托溴铵联合布地奈德对支气管哮喘患儿血清血管内皮生长因子(VEGF)、转化生长因子β_(1)(TGF-β_(1))、单核细胞趋化蛋白4(MCP-4)水平及肺功能的影响。方法选取2019年1月至2020年2月青岛大学附属医院儿科收治的100例支气管哮喘患儿,根据随机数字表法分为对照组和观察组,各50例。对照组采用布地奈德雾化吸入进行治疗,观察组使用布地奈德联合复方异丙托溴铵雾化吸入进行治疗,2组均治疗14 d。比较2组治疗14 d后的疗效和治疗期间症状消失时间,比较2组治疗前和治疗14 d后血清VEGF、TGF-β_(1)、MCP-4水平和肺功能。结果治疗14 d后,观察组总有效率高于对照组[94.0%(47/50)比76.0%(38/50)](P<0.05)。治疗期间,观察组咳嗽、气喘和喘鸣音消失时间较对照组显著缩短(均P<0.05)。治疗14 d后与治疗前比较,2组血清TGF-β_(1)、VEGF、MCP-4水平均降低,且观察组均低于对照组(均P<0.05)。治疗14 d后,2组用力肺活量(FVC)、第1秒用力呼气容积(FEV_(1))、峰值呼气流速均较治疗前升高,且观察组均高于对照组,观察组FEV_1/FVC较治疗前升高,且高于对照组(均P<0.05)。结论复方异丙托溴铵联合布地奈德对支气管哮喘患儿进行治疗,能显著降低患儿血清VEGF、TGF-β_(1)、MCP-4水平,抑制疾病进展,缓解临床症状,同时改善患儿肺功能,具有良好的治疗效果。 Objective To analyze the effects of compound ipratropium bromide combined with budesonide on vascular endothelial growth factor(VEGF),transforming growth factor-β_(1)(TGF-β_(1)),monocyte chemoattractant protein-4(MCP-4)levels and lung function in children with bronchial asthma.Methods From January 2019 to February 2020,100 children with bronchial asthma in the Affiliated Hospital of Qingdao University were selected.They were randomly divided into control group and observation group,with 50 cases in each group.The control group was treated with budesonide inhalation,while the observation group was treated with budesonide combined with compound ipratropium bromide inhalation.Both groups were treated for 14 d.The efficacy after 14 d of treatment and symptom disappearance time during treatment were compared between the two groups,and the levels of serum VEGF,TGF-β_(1),MCP-4 and lung function were compared before and after 14 d of treatment.Results After 14 d of treatment,the total effective rate in the observation group was higher than that in the control group[94.0%(47/50)vs76.0%(38/50)](P<0.05).During the treatment,the disappearance time of cough,asthma and wheezing in the observation group were significantly shorter than those in the control group(all P<0.05).Compared with those before treatment,the levels of serum TGF-β_(1),VEGF and MCP-4 in the two groups decreased after 14 d of treatment,and those in the observation group were lower than those in the control group(all P<0.05).After14 d of treatment,forced vital capacity(FVC),forced expiratory volume in the first second(FEV_(1))and peak expiratory flow rate(PEF)of the two groups were significantly higher than those before treatment,and those in the observation group were higher than those in the control group;FEV1/FVC in the observation group was higher than that before treatment and higher than that in the control group(both P<0.05).Conclusion Compound ipratropium bromide combined with budesonide in treatment of bronchial asthma can significantly reduce serum VEGF,TGF-β_(1),MCP-4 levels,inhibit disease progression,relieve clinical symptoms,and improve lung function of children with good therapeutic effect.
作者 张蓓 杨召川 王增兰 宋爱琴 Zhang Bei;Yang Zhaochuan;Wang Zenglan;Song Aiqin(Department of Pediatric Critical Care Medicine,the Affiliated Hospital of Qingdao University,Qingdao 266003,China;Department of Child Healthy the Affiliated Hospital of Qingdao University,Qingdao 266003,China;Department of iMboratory,Zibo Municipal Government Hospital,Shandong Province,Zibo 255000,China)
出处 《中国医药》 2021年第4期521-524,共4页 China Medicine
基金 国家自然科学基金(81700029)。
关键词 支气管哮喘 复方异丙托溴铵 布地奈德 血管内皮生长因子 转化生长因子β_(1) Bronchial asthma Compound ipratropium bromide Budesonide Vascular endothelial growth factor Transforming growth factor-β_(1)
  • 相关文献

参考文献9

二级参考文献98

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 2Tan NC, Chen Z,Soo WF, et al. Effects of a written asthma action plan on caregivers" management of children with asthma:a cross-sectional questionnaire survey [J]. Primary Care Respiratory Journal, 2013,22 (2) : 188-194.
  • 3Donohue KM,Miller RL,Perzanowski MS,et al. Prenatal and postnatal bisphenol A exposure and asthma develop- ment among inner-city children [J]. Journal of Allergy and Clinical Immunology, 2013,131 (3) :736-742.
  • 4Pinart M,Benet M,Annesi-Maesano I,et al. Comorbidity of eczema,rhinitis, and asthma in IgE-sensitised and non- IgE-sensitised children in MeDALL:a population-based cohort study [J]. The Lancet Respiratory Medicine,2014,2 (2) : 131-140.
  • 5Nishimura KK,Galanter JM,Roth LA,et al. Early-life air pollution and asthma risk in minority children. The GALA II and SAGE II studies [J]. Am J Respir Crit Care Med, 2013,188(3) :309-318.
  • 6. Sonnenschein-van der Voort AM,Arends LR,de Jongste JC,et al. Preterm birth,infant weight gain, and childhood asthma risk:a meta-analysis of 147,000 European chil- dren [J]. J Allergy Clin Immunol,2014,133(5) : 1317-1329.
  • 7Bertelsen RJ,Carlsen KC,Calafat AM,et al. Urinary biomark- ers for phthalates associated with asthma in Norwegian children [J]. Environ Health Perspect,2013,121(2) :251-256.
  • 8Mitchell EA,Beasley R, Bjirkst6n B, et al. The association between BMI,vigorous physical activity and television viewing and the risk of symptoms of asthma,rhinoconjunc- tivitis and eczema in children and adolescents:ISAAC Phase Three [J]. Clinical & Experimental Allergy,2013,43 (1):73-84.
  • 9Pruteanu AI,Chauhan BF,Zhang L,et al. Inhaled corticos- ter0ids in children with persistent asthma:dose-response effects on growth [J]. Cochrane Database Syst Rev,2014(7) : CD009878.
  • 10Kuzik BA. Inhaled corticosteroids in children with persis- tent asthma:effects on growth [J]. Paediatr Child Health, 2015,20(5) : 248-250.

共引文献2871

同被引文献182

引证文献18

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部